ArticleFrontiers in immunology2023

Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC.

Yu Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.